Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gossamer Bio
Biotech
BIO announces new CEO—Chutes & Ladders
BIO lands rare disease advocate John Crowley as CEO. Cyclerion Therapeutics picks EQRx leader for top spot. Sensorium selects new CEO.
Gabrielle Masson
,
Annalee Armstrong
Dec 8, 2023 9:30am
Gossamer cuts loose staff, ties future to tarnished Merck rival
May 10, 2023 6:30am
Gossamer halts work on BTK inhibitor after 2 patient deaths
Apr 4, 2023 4:30am
Gossamer pauses CNS med enrollment, citing risk-benefit profile
Mar 17, 2023 11:16am
Gossamer touts phase 2 win but investors are wary
Dec 6, 2022 11:09am
Women in biotech see Roe v. Wade ruling as a call to action
Jul 11, 2022 8:00am